De Luca, GiuseppeAlgowhary, MagdyUguz, BeratOliveira, Dinaldo C.Ganyukov, VladimirZimbakov, ZanCercek, MihaJensen, Lisette OkkelsLoh, Poay HuanCalmac, LucianFerrer, Gerard RouraQuadros, AlexandreMilewski, MarekDi Uccio, Fortunato Scottovon Birgelen, ClemensVersaci, FrancescoTen Berg, JurrienCasella, GianniLung, Aaron Wong SungKala, PetrGil, Jose Luis DiezCarrillo, XavierDirksen, MauritsBecerra-Munoz, Victor M.Lee, Michael Kang-YinJuzar, Dafsah ArifaJoaquim, Rodrigo de MouraDe Simone, CiroMilicic, DavorDavlouros, PeriklisBakraceski, NikolaZilio, FilippoDonazzan, LucaKraaijeveld, AdriaanGalasso, GennaroArpad, LuxMarinucci, LuciaGuiducci, VincenzoMenichelli, MaurizioScoccia, AlessandraYamac, Aylin HaticeMERT, KADİR UĞURRios, Xacobe FloresKovarnik, TomasKidawa, MichalMoreu, JoseFlavien, VincentFabris, EnricoMartinez-Luengas, Inigo LozanoBoccalatte, MarcoOjeda, Francisco BosaArellano-Serrano, CarlosCaiazzo, GianlucaCirrincione, GiuseppeKao, Hsien-LiFores, Juan SanchisVignali, LuigiPereira, HelderManzo-Silbermann, StephaneOrdonez, SantiagoOzkan, Alev AratScheller, BrunoLehtola, HeidiTeles, RuiMantis, ChristosAntti, YlitaloSilveira, Joao Antonio BrumBessonov, IvanZoni, RodrigoSavonitto, StefanoKochiadakis, GeorgeAlexopoulos, DimitriosUribe, Carlos E.Kanakakis, JohnFaurie, BenjaminGabrielli, GabrieleBarrios, Alejandro GutierrezBachini, Juan PabloRocha, AlexTam, Frankie Chor-CheungRodriguez, AlfredoLukito, Antonia AnnaBellemain-Appaix, AnnePessah, GustavoCortese, GiulianaParodi, GuidoBurgadha, Mohammed AbedKedhi, ElvinLamelas, PabloSuryapranata, HarryNardin, MatteoVerdoia, Monica2022-10-252022-10-252022-10-01De Luca G., Algowhary M., Uguz B., Oliveira D. C. , Ganyukov V., Zimbakov Z., Cercek M., Jensen L. O. , Loh P. H. , Calmac L., et al., -SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion-, ANGIOLOGY, 2022http://hdl.handle.net/20.500.12645/31167SARS-Cov-2 has been suggested to promote thrombotic complications and higher mortality. The aim of the present study was to evaluate the impact of SARS-CoV-2 positivity on in-hospital outcome and 30-day mortality in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) enrolled in the International Survey on Acute Coronary Syndromes ST-segment elevation Myocardial Infarction (ISACS-STEMI COVID-19 registry. The 109 SARS-CoV-2 positive patients were compared with 2005 SARS-CoV-2 negative patients. Positive patients were older (P = .002), less often active smokers (P = .002), and hypercholesterolemic (P = .006), they presented more often later than 12 h (P = .037), more often to the hub and were more often in cardiogenic shock (P = .02), or requiring rescue percutaneous coronary intervention after failed thrombolysis (P < .0001). Lower postprocedural Thrombolysis in Myocardial Infarction 3 flow (P = .029) and more thrombectomy (P = .046) were observed. SARS-CoV-2 was associated with a significantly higher in-hospital mortality (25.7 vs 7%, adjusted Odds Ratio (OR) [95% Confidence Interval] = 3.2 [1.71-5.99], P < .001) in-hospital definite in-stent thrombosis (6.4 vs 1.1%, adjusted Odds Ratio [95% CI] = 6.26 [2.41-16.25], P < .001) and 30-day mortality (34.4 vs 8.5%, adjusted Hazard Ratio [95% CI] = 2.16 [1.45-3.23], P < .001), confirming that SARS-CoV-2 positivity is associated with impaired reperfusion, with negative prognostic consequences.ArticleWOS:00086619390000110.1177/0003319722112935136222189